A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit

References

• Abushanab, D., Al-Badriyeh, D., Liew, D., & Ademi, Z. (2022). First-line treatment with empagliflozin and metformin combination versus standard care for patients with type 2 diabetes mellitus and cardiovascular disease in Qatar. A cost-effectiveness analysis. Current Problems in Cardiology, 47(6), 100852. https://doi.org/10.1016/j.cpcardiol.2021.100852. Epub 2021 Apr 6.
   PubMed Web of Science ®Google Scholar
• Abushanab, D., Rouf, P. A., Al Hail, M., Kamal, R., Viswanathan, B., Parappil, H., Elkassem, W., Al-Shaibi, S., & Al-Badriyeh, D. (2021). Cost-effectiveness of oral versus intravenous ibuprofen therapy in preterm infants with patent ductus arteriosus in the neonatal intensive care setting: A cohort-based study. Clinical Therapeutics, 43(2), 336–348. https://doi.org/10.1016/j.clinthera.2020.12.004
   PubMed Web of Science ®Google Scholar
• Al Ansari, E., Qeretli, R., Fayed, M., Altammami, H., Akhras, L., Alalaiyan, S., Alhazzani, F., Binmanee, A., Almidani, E., & Khadawardi, E. (2018). Caffeine therapy practice in the management of apnea of prematurity: National survey in Saudi Arabia. Journal of Clinical Neonatology, 7(4), 217–223. https://doi.org/10.4103/jcn.JCN_45_18
   Google Scholar
• Al-Badriyeh, D., Hssain, A. A., & Abushanab, D. (2022). Cost-effectiveness analysis of out-of-hospital versus in-hospital extracorporeal cardiopulmonary resuscitation for out-hospital refractory cardiac arrest. Current Problems in Cardiology, 47(12), 101387. https://doi.org/10.1016/j.cpcardiol.2022.101387. Epub 2022 Sep 5.
   PubMed Web of Science ®Google Scholar
• Alhersh, E., Abushanab, D., Al-Shaibi, S., & Al-Badriyeh, D. (2020). Caffeine for the treatment of apnea in the neonatal intensive care unit: A systematic overview of meta-analyses. Pediatric Drugs, 22(4), 399–408. https://doi.org/10.1007/s40272-020-00404-4. PMID: 32488731; PMCID: PMC7266675.
   PubMed Web of Science ®Google Scholar
• Al-Shaibi, S., Abushanab, D., Abounahia, F., Awaisu, A., & Al-Badriyeh, D. (2023). Cost-effectiveness analysis of ibuprofen versus indomethacin or paracetamol for the treatment of patent ductus arteriosus in preterm neonates. Current Problems in Cardiology, 48(9), 101751. https://doi.org/10.1016/j.cpcardiol.2023.101751. Epub 2023 Apr 21.
   PubMed Web of Science ®Google Scholar
• Aujard, Y. (1990). Caffeine in the treatment of apnea in premature infants. Archives Francaises de Pediatrie, 47(10), 763.
   PubMedGoogle Scholar
• Ban, J. E. (2017). Neonatal arrhythmias: Diagnosis, treatment, and clinical outcome. Korean Journal of Pediatrics, 60(11), 344–352. https://doi.org/10.3345/kjp.2017.60.11.344. Epub 2017 Nov 27.
   PubMedGoogle Scholar
• Brattstrom, P., Russo, C., Ley, D., & Bruschettini, M. (2019). High-versus low-dose caffeine in preterm infants: A systematic review and meta-analysis. Acta Paediatrica, 108(3), 401–410. https://doi.org/10.1111/apa.14586
   PubMed Web of Science ®Google Scholar
• Bruschettini, M., Brattström, P., Russo, C., Onland, W., Davis, P. G., & Soll, R. (2023). Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity. Cochrane Database of Systematic Reviews, 2023(4), CD013873. https://doi.org/10.1002/14651858.CD013873.pub2
   Google Scholar
• Cameron, D., Ubels, J., & Norström, F. (2018). On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review. Global Health Action, 11(1), 1447828. https://doi.org/10.1080/16549716.2018.1447828
   PubMed Web of Science ®Google Scholar
• Chen, J., Jin, L., & Chen, X. (2018). Efficacy and safety of different maintenance doses of caffeine citrate for treatment of apnea in premature infants: A systematic review and meta-analysis. BioMed Research International, 9061234. https://doi.org/10.1155/2018/9061234
   PubMed Web of Science ®Google Scholar
• Consensus Guidelines for Management of Apnea of Prematurity UCSF NCNC (Northern California Neonatology Consortium). (2017). UCSF Medical Center. Accessed March 20, 2024, from https://medconnection.ucsfbenioffchildrens.org/apnea-guidelines.
   Google Scholar
• Dukhovny, D., Lorch, S. A., Schmidt, B., Doyle, L. W., Kok, J. H., Roberts, R. S., Kamholz, K. L., Wang N., Mao W., Zupancic, J. A. F., & Caffeine for Apnea of Prematurity Trial Group. (2011). Economic evaluation of caffeine for apnea of prematurity. Pediatrics, 127(1), e146–e155. https://doi.org/10.1542/peds.2010-1014
   PubMed Web of Science ®Google Scholar
• Eichenwald, E. C. (2016). Apnea of Prematurity. Pediatrics, 137(1), e20153757. https://doi.org/10.1542/peds.2015-3757
   Web of Science ®Google Scholar
• Gidwani, R., & Russell, L. B. (2020). Estimating transition probabilities from published evidence: A tutorial for decision modelers. Pharmacoeconomics, 38(11), 1153–1164. https://doi.org/10.1007/s40273-020-00937-z
   PubMed Web of Science ®Google Scholar
• Gray, P. H., Flenady, V. J., Charles, B. G., Steer, P. A., & Group, C. C. S. (2011). Caffeine citrate for very preterm infants: Effects on development, temperament and behaviour. Journal of Paediatrics and Child Health, 47(4), 167–172. https://doi.org/10.1111/j.1440-1754.2010.01943.x
   PubMed Web of Science ®Google Scholar
• Guo, H. L., Long, J. Y., Hu, Y. H., Liu, Y., He, X., Li, L., Xia, Y., Ding, X. S., Chen, F., Xu, J., & Cheng, R. (2022). Caffeine therapy for apnea of prematurity: Role of the circadian CLOCK gene polymorphism. Frontiers in Pharmacology, 12, 724145. doi:10.3389/fphar.2021.724145. PMID: 35145399; PMCID: PMC8822171.
   PubMed Web of Science ®Google Scholar
• Henderson-Smart, D. J., & De Paoli, A. G. (2010). Methylxanthine treatment for apnoea in preterm infants. Cochrane Database of Systematic Reviews, 2010(12), CD000140.
   Google Scholar
• Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., Mauskopf, J., Mullins, C. D., Petrou, S., Pwu, R. F., Staniszewska, S. & CHEERS 2022 ISPOR Good Research Practices Task Force. (2022). Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations. BMC Medicine, 20(1), 23. https://doi.org/10.1186/s12916-021-02204-0
   PubMed Web of Science ®Google Scholar
• Kaddoura, R., Abushanab, D., Arabi, A. R., Alyafei, S. A., & Al-Badriyeh, D. (2022). Cost-effectiveness analysis of sacubitril/valsartan for reducing the use of implantable cardioverter-defibrillator (ICD) and the risk of death in ICD-eligible heart failure patients with reduced ejection fraction. Current Problems in Cardiology, 47(12), 101385. https://doi.org/10.1016/j.cpcardiol.2022.101385. Epub 2022 Sep 5.
   PubMed Web of Science ®Google Scholar
• Kreutzer, K., & Bassler, D. (2014). Caffeine for apnea of prematurity: A neonatal success story. Neonatology, 105(4), 332–336. https://doi.org/10.1159/000360647
   PubMed Web of Science ®Google Scholar
• Kulkarni, A. P., & Agarwal, V. (2008). Extubation failure in intensive care unit: predictors and management. Indian Journal of Critical Care Medicine, 12(1), 1–9. https://doi.org/10.4103/0972-5229.40942
   PubMedGoogle Scholar
• Marseille, E., Larson, B., Kazi, D. S., Kahn, J. G., & Rosen, S. (2015). Thresholds for the cost-effectiveness of interventions: Alternative approaches. Bulletin of the World Health Organization, 93(2), 118–124. https://doi.org/10.2471/BLT.14.138206. Epub 2014 Dec 15.
   PubMed Web of Science ®Google Scholar
• Mohammed, S., Nour, I., Shabaan, A. E., Shouman, B., Abdel-Hady, H., & Nasef, N. (2015). High versus low-dose caffeine for apnea of prematurity: A randomized controlled trial. European Journal of Pediatrics, 174(7), 949–956. https://doi.org/10.1007/s00431-015-2494-8. Epub 2015 Feb 3. PMID: 25644724.
   PubMed Web of Science ®Google Scholar
• Montenegro, B. L., Amberson, M., Veit, L., Freiberger, C., Dukhovny, D., & Rhein, L. M. (2017). Economics of home monitoring for apnea in late preterm infants. Respiratory Care, 62(1), 42–48. https://doi.org/10.4187/respcare.04954
   PubMed Web of Science ®Google Scholar
• NHSGGC Guidelines. (2023). NHSGGC Paediatrics for Health Professionals. Accessed March 20, 2024, from https://www.clinicalguidelines.scot.nhs.uk/nhsggc-guidelines/nhsggc-guidelines/.
   Google Scholar
• Qatar Inflation Rate. (2023). Accessed August 15, 2023, from https://tradingeconomics.com/qatar/inflation-cpi.
   Google Scholar
• Schmidt, B., Roberts, R. S., Anderson, P. J., Asztalos, E. V., Costantini, L., Davis, P. G., Dewey, D., D'Ilario, J., Doyle, L. W., Grunau, R. E., Moddemann, D., Nelson, H., Ohlsson, A., Solimano, A., Tin, W., & Caffeine for Apnea of Prematurity Trial Group. (2017). Academic performance, motor function, and behavior 11 years after neonatal caffeine citrate therapy for apnea of prematurity. JAMA Pediatrics, 171(6), 564–572. https://doi.org/10.1001/jamapediatrics.2017.0238
   PubMed Web of Science ®Google Scholar
• Schmidt, B., Roberts, R. S., Davis, P., Doyle, L. W., Barrington, K. J., Ohlsson, A., Solimano, A., Tin, W., & Caffeine for Apnea of Prematurity Trial Group. (2006). Caffeine therapy for apnea of prematurity. New England Journal of Medicine, 354(20), 2112–2121. https://doi.org/10.1056/NEJMoa054065
   PubMed Web of Science ®Google Scholar
• Specialist neonatal respiratory care for babies born preterm NICE guideline [NG124]. (2019). Retrieved April 1, 2024, from https://www.nice.org.uk/guidance/ng124/chapter/Recommendations. Updated 04/03/2019.
   Google Scholar
• Startship Children's Hospital. (2023). Caffeine citrate. Retrieved April 3, 2024, from https://starship.org.nz/guidelines/caffeine/.
   Google Scholar
• Steer, P. A., & Henderson-Smart, D. J. (2000). Caffeine versus theophylline for apnea in preterm infants. Cochrane Database of Systematic Review, (2), CD000273. https://doi.org/10.1002/14651858.CD000273
   PubMedGoogle Scholar
• Stone, D. L., & Rosopa, P. J. (2017). The Advantages and limitations of using meta-analysis in human resource management research. Human Resource Management Review, 27(1), 1–7. https://doi.org/10.1016/j.hrmr.2016.09.001
   Web of Science ®Google Scholar
• The Royal Children’s Hospital Melbourse. (2024). Caffeine citrate. Retrieved April 3, 2024, from https://www.rch.org.au/piper/neonatal_medication_guidelines/Caffeine_Citrate/.
   Google Scholar
• Vemer, P., Corro Ramos, I., van Voorn, G. A., Al, M. J., & Feenstra, T. L. (2016). Advishe: A validation-assessment tool of health-economic models for decision makers and model users. Pharmacoeconomics, 34(4), 349–361. https://doi.org/10.1007/s40273-015-0327-2
   PubMed Web of Science ®Google Scholar
• Vliegenthart, R., Miedema, M., Hutten, G. J., van Kaam, A. H., & Onland, W. (2018). High versus standard dose caffeine for apnoea: A systematic review. Archives of Disease in Childhood - Fetal and Neonatal Edition, 103(6), F523–F529. https://doi.org/10.1136/archdischild-2017-313556
   PubMed Web of Science ®Google Scholar
• Voskanyan, Y. V. (2018). Safety of patients and adverse events related thereto in medicine. Angiologiia i Sosudistaia Khirurgiia, 24(4), 11–17.
   PubMedGoogle Scholar
• The World Bank. (2022). The World Bank Open Data. Accessed March 21, 2024, from https://data.worldbank.org/country/qatar.
   Google Scholar